LifeMD (LFMD) Stock Forecast & Price Target

LifeMD Inc. demonstrated significant growth in its Telehealth segment, with an active subscriber base increasing by 16% year-over-year to approximately 323,000 by the end of 4Q25, highlighting the company's successful patient acquisition strategies. The company's total revenue reached $60.2 million, achieving a 12.7% year-over-year growth, with Telehealth revenue itself rising to $47.3 million, up 17.4% year-over-year, reflecting persistent demand for virtual medical care. Additionally, LifeMD's gross margin expanded to an impressive 87%, indicating a favorable revenue mix and reinforcing the company's position to capitalize on the growing healthcare market.

LifeMD has demonstrated slower revenue growth, reporting $60.2 million in revenue for the most recent quarter, which fell short of consensus estimates of $62.6 million. The company is also facing significant operational challenges, including difficulties in acquiring and retaining patients, and a potential inability to achieve profitability, compounded by heightened competition in the telehealth sector. Additionally, LifeMD has revised its full-year revenue guidance downward, with expectations for telehealth revenue now at $192 million to $193 million, indicating potential headwinds for future financial performance.